Measuring glucocorticoid receptor expression in vivo with PET

The glucocorticoid receptor (GR) is an emerging drug target for several common and deadly solid tumors like breast and prostate cancer, and clinical trials studying the antitumor effects of GR antagonists are beginning. Since GR expression can be variable in tumor cells, and virtually all normal mam...

Descripción completa

Detalles Bibliográficos
Autores principales: Truillet, Charles, Parker, Matthew F.L., Huynh, Loc T., Wei, Junnian, Jami, Khaled M., Wang, Yung-Hua, Shen, Yuqin S., Sriram, Renuka, Wilson, David M., Kurhanewicz, John, Evans, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945515/
https://www.ncbi.nlm.nih.gov/pubmed/29755660
http://dx.doi.org/10.18632/oncotarget.24911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945515/
https://www.ncbi.nlm.nih.gov/pubmed/29755660
http://dx.doi.org/10.18632/oncotarget.24911

Ejemplares similares